Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phendimetrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 5/20 | 0.41 |
| ▸ | SLC6A3 known ✓ | Q01959 | 5/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phendimetrazine SCHEMBL29353044 | 1.00 | HTR1A (0.75) | HTR1AKDM4EBLMALOX15SLC6A2 | |
| Phendimetrazine SCHEMBL15064941 | 1.00 | HTR1A (0.75) | HTR1AKDM4EBLMALOX15SLC6A2 | |
| Phendimetrazine SCHEMBL29554688 | 1.00 | HTR1A (0.75) | HTR1AKDM4EBLMALOX15SLC6A2 | |
| Phendimetrazine SCHEMBL160376 | 1.00 | HTR1A (0.75) | HTR1AKDM4EBLMALOX15SLC6A2 | |
| Phendimetrazine SCHEMBL10613088 | 0.99 | HTR1A (0.73) | HTR1AKDM4EBLMALOX15SLC6A2 | |
| Phendimetrazine SCHEMBL21603017 | 0.88 | HTR1A (0.57) | HTR1AKDM4EBLMALOX15CYP2D6 | |
| Phendimetrazine SCHEMBL15064942 | 0.87 | HTR1A (1.00) | HTR1ASLC6A2SLC6A3HTR2BADRA1A | |
| Phendimetrazine SCHEMBL49481 | 0.87 | HTR1A (1.00) | HTR1ASLC6A2SLC6A3HTR2BADRA1A | |
| Phendimetrazine SCHEMBL344020 | 0.87 | HTR1A (1.00) | HTR1ASLC6A2SLC6A3HTR2BADRA1A | |
| Phendimetrazine SCHEMBL598950 | 0.87 | HTR1A (1.00) | HTR1ASLC6A2SLC6A3HTR2BADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5615 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4654966-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY AND DISEASES ASSOCIATED WITH FAT CELL ENLARGEMENT | MELLICELL, INC. (US) | 2025-12-03 | — | — | EP | claimed |
| US-12378579-B2 | Method to produce the anti-microbial diterpenoid leubethanol and related serrulatane-type diterpenes | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-08-05 | — | — | US | claimed |
| WO-2025137653-A1 | METHODS AND COMPOSITIONS OF POLYCYCLIC AND A DUAL ACTING NITROXIDE COMPOUNDS FOR TREATMENT OF FAT CELL ASSOCIATED DISEASES | MELLICELL, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| WO-2024159211-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY AND DISEASES ASSOCIATED WITH FAT CELL ENLARGEMENT | MELLICELL, INC. (US) | 2024-08-02 | — | — | WO | claimed |
| CN-117883438-A | Method for treating malignant lymphoproliferative diseases | 开动疗法公司 | 2024-04-16 | — | — | CN | claimed |
| US-11896598-B2 | Appetite suppressant compositions and methods thereof | Red Mountain Med Spa, LLC (US) | 2024-02-13 | — | — | US | claimed |
| EP-2552202-B1 | METHODS AND COMPOSITIONS FOR WEIGHT LOSS | SDG INC (US) | 2023-07-26 | — | — | EP | claimed |
| WO-2023126672-A1 | METHOD AND DEVICE FOR REMOVAL OF CIRCULATING CELL FREE DNA | SANTERSUS AG (CH) | 2023-07-06 | — | — | WO | claimed |
| US-20230193328-A1 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2023-06-22 | — | — | US | claimed |
| EP-1119345-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2001-08-01 | — | — | EP | claimed |
| CN-1267342-A | Method and device for regulating concentration of substaces in electrolytes | ATOTECH DEUTSCHLAND GMBH (DE) | 2000-09-20 | — | — | CN | claimed |
| WO-2000021504-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| EP-0935523-A4 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GEN MILLS INC (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| US-5795880-A | Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent | LOUISIANA STATE UNIVERSITY MEDICAL CENTER FOUNDATION (US) | 1998-08-18 | — | — | US | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| US-5527788-A | Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent | LOUISIANA STATE UNIV. MEDICAL CENTER FOUNDATION (US) | 1996-06-18 | — | — | US | claimed |
| WO-1994000401-A1 | METHOD FOR PRODUCING CONSTRUCTION DECORATIVE PRODUCTS AND/OR DECORATIVE CLADDING | LOW WATER BINDER, S.A. (ES) | 1994-01-06 | — | — | WO | claimed |
| CN-87106313-A | The improvement of organic compound | — | 1988-05-04 | — | — | CN | claimed |